skip to primary navigationskip to content

Professor David Rowitch

Rowitch David 128Professor David Rowitch

Glial cells and response to injury


Laboratory: Cambridge Stem Cell Institute, Clifford Allbutt Building, Cambridge Biomedical Campus.

Departmental Affiliation: Paediatrics


850 Rowitch research image 2 1ratio



David Rowitch, MD PhD ScD is Professor and Head of Paediatrics at University of Cambridge. He holds a joint appointment at UCSF (Pediatrics and Neurological Surgery). He is a neonatologist and neuroscientist whose laboratory investigates genetic factors that determine development and diversity of glial cells of the brain and the response to injury. He has applied these principles to better understand white matter injury in premature infants, brain cancer and leukodystrophy. Rowitch leads the first human clinical trial of direct neural stem cell transplantation focused on the rare and fatal leukodystrophy, Pelizaeus-Merzbacher Disease (PMD). His work in the field of neurobiology has earned him numerous awards. He became a Howard Hughes Medical Institute Investigator in 2008 and Professor of Paediatrics at Cambridge University and Wellcome Trust Senior Investigator in 2016. His interest in precision medicine focuses on applications of genomic technologies to diagnose and better understand the biological basis and rational treatment of rare neurological disorders. 


Group Members

Steffan Holmquist


Plain English 


Key Publications